Table 2.
Comparison of the sexual functions and quality of life before and during COVID-19 epidemic period
| Variables | Before COVID-period | During COVID-Period∗ | Mean difference | 95% CI | P value |
|---|---|---|---|---|---|
| Sexual intercourses/month (mean ± SD) | 6.3 ± 1.9 | 2.3 ± 1.8 | −3.9 ± 1.2 | (−4.5; −3.2) | <.0001 |
| FSFI total (mean ± SD) | 29.2 ± 4.2 | 19.2 ± 3.3 | −9.7 ± 2.6 | (−14.3; −6.8) | <.0001 |
| Desire (mean ± SD) | 3.8 ± 0.9 | 3.2 ± 1.1 | −0.8 ± 0.5 | (−1.2; −0.7) | .0007 |
| Arousal (mean ± SD) | 4.8 ± 0.9 | 3.6 ± 1.1 | −1.1 ± 0.9 | (−1.6; −0.6) | <.0001 |
| Lubrication (mean ± SD) | 4.9 ± 1.6 | 4.4 ± 1.7 | −0.4 ± 0.5 | (−0.8; 0.2) | .07 |
| Orgasm (mean ± SD) | 4.7 ± 0.8 | 4.2 ± 1.1 | −0.6 ± 0.4 | (−1.0; −0.3) | .0009 |
| Satisfaction (mean ± SD) | 5.9 ± 1.3 | 4.2 ± 1.4 | −1.6 ± 0.9 | (−2.3; −0.9) | <.0001 |
| Pain (mean ± SD) | 4.8 ± 1.1 | 4.5 ± 1.2 | −0.3 ± 0.2 | (−0.6; 0.2) | .11 |
| FSDS (mean ± SD) | 9.3 ± 5.5 | 20.1 ± 5.2 | 10.8 ± 3.4 | (4.2–14.7) | <.0001 |
| SF-36 (mean ± SD) | 82.2 ± 10.2 | 64.2 ± 11.8 | −17.8 ± 6.7 | (−18.4; −9.6) | <.0001 |
FSDS = Female Sexual Distress Scale; FSFI = Female Sexual Function Index; SD = standard deviation; SF-36 = The Short-Form (36) Health Survey.
∗
4 weeks after the start of social containment measures.